Serum uric acid and the incidence of CKD and hypertension

被引:38
|
作者
Kuriyama, Satoru [2 ]
Maruyama, Yukio [2 ]
Nishio, Shinichiro [2 ]
Takahashi, Yasuhito [2 ]
Kidoguchi, Satoshi [2 ]
Kobayashi, Chisa [2 ]
Takahashi, Daisuke [2 ]
Sugano, Naoki [2 ]
Hosoya, Tatsuo [1 ]
Yokoo, Takashi [2 ]
机构
[1] Jikei Univ, Sch Med, Dept Pathophysiol & Therapy Chron Kidney Dis, Tokyo 1058461, Japan
[2] Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med,Minato Ku, Tokyo 1058461, Japan
关键词
Uric acid; CKD; Hypertension; Estimated glomerular filtration rate; CARDIOVASCULAR-DISEASE; RISK-FACTOR; RENAL-DISEASE; KIDNEY-DISEASE; HYPERURICEMIA; PROGRESSION; COHORT; METAANALYSIS; MORTALITY; GOUT;
D O I
10.1007/s10157-015-1120-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Uric acid (UA) levels correlate positively with the prevalence of chronic kidney disease (CKD) and/or hypertension. We tested the hypothesis that UA may also have a link to a new incidence of CKD and hypertension. Methods Study design is a cohort study and the predictor is UA levels. Of the 15,470 screened cases, 8223 participants without CKD were eligible for the analysis of the incidence of CKD. Among these CKD candidates, 7569 participants were eligible for the analysis of the new development of hypertension. The observation period was 4 years. Results Relationship of UA with new cases of CKD. Higher UA levels had a closer association with the new development of CKD; 1.1 % (UA < 5 mg/dL), 1.5 % (5.0-5.9 mg/dL), 1.7 % (6.0-6.9 mg/dL), and 3.4 % (>= 7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the CKD development were eGFR [Hazard Ratio (HR) 0.816, 95 % confidence intervals (CI) 0.791-0.840] and male gender (HR 0.562, 95 % CI 0.322-0.982). UA levels and new development of hypertension. Higher UA levels had a closer association with the new development of hypertension; 5.0 % (UA < 5 mg/dL), 8.9 % (5.0-5.9 mg/dL), 10.6 % (6.0-6.9 mg/dL), and 11.8 % (>= 7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the hypertension development were BMI (HR 1.190, 95 % CI 1.155-1.226), age (HR 1.021, 95 % CI 1.010-1.032), HDL-cholesterol (HR 1.013, 95 % CI 1.007-1.019), male gender (HR 1.791, 95 % CI 1.338-2.395), UA level (HR 1.112, 95 % CI 1.024-1.207), and eGFR (HR 1008, 95 % CI 1.002-1.013). Furthermore, the logistic analysis showed that the odds ratio (OR) to estimate hypertension in the high UA group (UA >= 7 mg/dL; OR 1.33, 95 % CI 1.01-1.80) was greater than that in the low UA group (UA < 5 mg/dL). Kaplan-Meier analysis also confirmed the finding that the higher the UA levels the greater the hypertension development (p < 0.001 by the Log-rank test and Cox proportional hazard analysis). Conclusion High UA levels are associated with the new development of hypertension, but not with the incidence of CKD.
引用
收藏
页码:1127 / 1134
页数:8
相关论文
共 50 条
  • [1] Serum uric acid and the incidence of CKD and hypertension
    Satoru Kuriyama
    Yukio Maruyama
    Shinichiro Nishio
    Yasuhito Takahashi
    Satoshi Kidoguchi
    Chisa Kobayashi
    Daisuke Takahashi
    Naoki Sugano
    Tatsuo Hosoya
    Takashi Yokoo
    [J]. Clinical and Experimental Nephrology, 2015, 19 : 1127 - 1134
  • [2] The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
    Yukimasa Iwata
    Shoki Notsu
    Yushi Kawamura
    Waka Mitani
    Shinjiro Tamai
    Madoka Morimoto
    Masafumi Yamato
    [J]. Scientific Reports, 13 (1)
  • [3] The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
    Iwata, Yukimasa
    Notsu, Shoki
    Kawamura, Yushi
    Mitani, Waka
    Tamai, Shinjiro
    Morimoto, Madoka
    Yamato, Masafumi
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [4] Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence
    Sundström, J
    Sullivan, L
    D'Agostino, RB
    Levy, D
    Kannel, WB
    Vasan, RS
    [J]. HYPERTENSION, 2005, 45 (01) : 28 - 33
  • [5] Associations between serum uric acid levels and the incidence of hypertension and atrial fibrillation
    Karamanou, A.
    Kallistratos, M. S.
    Poulimenos, L. E.
    Vergis, K.
    Martinaios, A.
    Kouremenos, N.
    Vrakas, S.
    Koukouzeli, A.
    Pagoni, S.
    Manolis, A. J.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 703 - 703
  • [6] ASSOCIATIONS BETWEEN SERUM URIC ACID LEVELS AND THE INCIDENCE OF HYPERTENSION AND ATRIAL FIBRILLATION
    Karamanou, A.
    Kallistratos, M. S.
    Poulimenos, L. E.
    Kouremenos, N.
    Vergis, K.
    Martinaios, A.
    Zacharopoulou, I.
    Vrakas, S.
    Koukouzeli, A.
    Chamodraka, E.
    Siama, A.
    Pagoni, S.
    Manolis, A. J.
    [J]. JOURNAL OF HYPERTENSION, 2015, 33 : E372 - E373
  • [7] Serum Uric Acid and Risk of CKD in Type 2 Diabetes
    De Cosmo, Salvatore
    Viazzi, Francesca
    Pacilli, Antonio
    Giorda, Carlo
    Ceriello, Antonio
    Gentile, Sandro
    Russo, Giuseppina
    Rossi, Maria C.
    Nicolucci, Antonio
    Guida, Pietro
    Feig, Daniel
    Johnson, Richard J.
    Pontremoli, Roberto
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (11): : 1921 - 1929
  • [8] THE SERUM URIC ACID CONCENTRATION IN ESSENTIAL HYPERTENSION
    STANTON, JR
    FREIS, ED
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1947, 66 (01): : 193 - 194
  • [9] Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study
    Fengjiang Wei
    Ning Sun
    Chunyou Cai
    Shuzhi Feng
    Jianli Tian
    Wentao Shi
    Weili Xu
    Yaogang Wang
    Xilin Yang
    Wei-Dong Li
    [J]. Journal of Translational Medicine, 14
  • [10] Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study
    Wei, Fengjiang
    Sun, Ning
    Cai, Chunyou
    Feng, Shuzhi
    Tian, Jianli
    Shi, Wentao
    Xu, Weili
    Wang, Yaogang
    Yang, Xilin
    Li, Wei-Dong
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14